Shared Decision Making for Patients With First-admission Schizophrenia

December 29, 2015 updated by: Yokohama City University

Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial

To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shizuoka
      • Numazu, Shizuoka, Japan
        • Numazu Chuou Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admitted to an acute care psychiatric ward.
  • Diagnosed with schizophrenia (ICD-10 codes: F20-F29)
  • Aged 16 to 65 years old at admission
  • No prior experience of psychiatric admission (first-admission)

Exclusion Criteria:

  • Diagnosed with moderate to severe mental retardation
  • Diagnosed with organic mental disorders (ICD10 codes: F00-F09)
  • Having poor Japanese language skill
  • Severe conceptual disorganization as measured by brief psychiatric rating scale of 5 or more.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Shared Decision Making
The present SDM intervention is based on principles derived from previous randomized controlled trials of SDMs. SDM meetings comprise at least 4 weekly 20 minutes sessions. Meetings have at least three professionals: a case manager (psychiatrists or nurses), a primary doctor, and a nurse/social worker. The focus of the meeting is to empower patients to discuss their attitudes and preferences toward treatments.
The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.
No Intervention: Usual Care
Patients with no special program about decision making.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Within 7days before the date of discharge
Within 7days before the date of discharge

Secondary Outcome Measures

Outcome Measure
Time Frame
Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10)
Time Frame: Within 7days before the date of discharge
Within 7days before the date of discharge
Treatment continuation as measured by the rate of outpatient attendance during the 30 days
Time Frame: 6 months after discharge
6 months after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yoshio Hirayasu, PhD, Department of Psychiatry, Yokohama City University School of Medical

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

May 27, 2013

First Submitted That Met QC Criteria

May 30, 2013

First Posted (Estimate)

June 5, 2013

Study Record Updates

Last Update Posted (Estimate)

December 30, 2015

Last Update Submitted That Met QC Criteria

December 29, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • SDMS-S

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Shared Decision Making

Subscribe